Lumida
/BRKR
⌘K
Bruker Corp

Bruker Corp

BRKR
$53.43USD-0.24%-0.13 today

MARKET CAP

8.1B

P/E (TTM)

FWD P/E

DAY RANGE

$53 – $54

52W RANGE

$30
$65

AI Summary

Stalk
TrimMedium

BRKR has broken below its intermediate EMAs and horizontal support, indicating structural weakness. Medium-term directional asymmetry favors further downside toward the 50-day SMA, but RSI near oversold and extended price suggests potential for a short-term bounce, warranting deferred bearish execution. Under a High Momentum strategy, trims should target rallies into the 9/20-day EMA resistance zone.

  • Q2 revenue $839M (+5.2% YoY) driven by 10% organic scientific instrument bookings.
  • Non-GAAP EPS $0.49 (+53% YoY) and operating margin expanded to 14.1%.
  • Persistent U.S. academic order weakness drags overall organic revenue growth.
Full analysis →
STATEMENT·Income statement
USD · GAAP
METRICFY 2021FY 2022FY 2023FY 2024FY 2025TREND
Sales, Adj.$2.4B$2.5B$3.0B$3.4B$3.4B
YoY %+21.7%+4.7%+17.1%+13.6%+2.1%
P / Sales5.3x4.1x3.6x2.6x2.1x
EV / Sales5.9x4.8x4.4x3.7x3.1x
Gross Profit, Adj.$1.2B$1.3B$1.5B$1.6B$1.6B
YoY %+28.7%+7.9%+15.9%+9.0%-4.4%
Margin %50.0%51.6%51.0%49.0%45.9%
EV / Gross Profit11.8x9.3x8.6x7.6x6.7x
EBITDA, Adj.$516.7M$551.2M$551.8M$436.9M$385.0M
YoY %+46.1%+6.7%+0.1%-20.8%-11.9%
Margin %21.4%21.8%18.6%13.0%11.2%
EV / EBITDA27.7x22.0x23.5x28.8x27.5x
EBIT$413.3M$432.7M$436.9M$253.1M$68.2M
YoY %+66.5%+4.7%+1.0%-42.1%-73.1%
Margin %17.1%17.1%14.7%7.5%2.0%
EV / EBIT34.7x28.1x29.7x49.7x155.2x
Net Income$277.1M$296.6M$427.2M$113.1M$-22.5M
YoY %+75.6%+7.0%+44.0%-73.5%-119.9%
Net Margin11.5%11.7%14.4%3.4%-0.7%
EPS (GAAP)$1.81$1.99$2.90$0.76-$0.15
YoY %+77.5%+9.9%+45.7%-73.8%-119.7%